New diabetes drug HMS1005 enters first human tests
Disease control
Recruiting now
This early-stage trial is testing a new drug, HMS1005, in 40 people with type 2 diabetes. The main goal is to check the drug's safety and how the body processes it. Researchers will also look at how it affects blood sugar levels over 24 hours. Participants will receive either the…
Phase: PHASE1 • Sponsor: Hua Medicine Limited • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC